A novel microfluidic device integrating focus-separation speed reduction design and trap arrays for high-throughput capture of circulating tumor cells
- 14 October 2020
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Lab on a Chip
- Vol. 20 (22) , 4094-4105
Abstract
Isolation and analysis of circulating tumor cells (CTCs) from peripheral blood provides a potential way to detect and characterize cancer. Existing technologies to separate or capture CTCs from whole blood still have issues with sample throughput, separation efficiency or stable efficiency at different flow rates. Here, we proposed a new concept to capture rare CTCs from blood by integrating a triangular prism array-based capture apparatus with streamline-based focus-separation speed reduction design. The focus-separation design could focus and maintain CTCs, while removing a considerable proportion of liquid (98.9%) containing other blood cells to the outlet, therefore, a high CTC capture efficiency could be achieved in the trap arrays with a high initial flow rate. It is worth mentioning that the new design works well over a wide range of flow rates, so it does not require the stability of the flow rate. The results showed that this novel integrated chip can achieve a sample throughput from 5 to 40 mL h−1 with a stable and high CTC capture efficiency (up to 94.8%) and high purity (up to 4 log white blood cells/WBC depletion). The clinical experiment showed that CTCs including CTC clusters were detected in 11/11 (100.0%) patients (mean = 31 CTCs mL−1, median = 25 CTCs mL−1). In summary, our chip enriches and captures CTCs based on physical properties, and it is simple, cheap, fast, and efficient and has low requirements on flow rate, which is very suitable for large-scale application of CTC testing in clinics.Keywords
Funding Information
- National Natural Science Foundation of China (11434001)
- National Natural Science Foundation of China (11674010)
- National Natural Science Foundation of China (11774011)
- National Natural Science Foundation of China (11974002)
- National Key Research and Development Program of China (SQ2018YFA090070-03)
- National Key Research and Development Program of China (2020YFA0906900)
This publication has 44 references indexed in Scilit:
- Molecular characterization of breast cancer CTCs associated with brain metastasisNature Communications, 2017
- Longitudinally collected CTCs and CTC-clusters and clinical outcomes of metastatic breast cancerBreast Cancer Research and Treatment, 2016
- A collective route to metastasis: Seeding by tumor cell clustersScience, 2016
- Targeting metastasisNature Reviews Cancer, 2016
- Circulating tumor cell detection in high-risk non-metastatic prostate cancerJournal of Cancer Research and Clinical Oncology, 2014
- Isolation of circulating tumor cells using a microvortex-generating herringbone-chipProceedings of the National Academy of Sciences, 2010
- Cancer metastasis as a therapeutic targetEuropean Journal of Cancer, 2010
- Significance of Circulating Tumor Cells Detected by the CellSearch System in Patients with Metastatic Breast Colorectal and Prostate CancerJournal of Oncology, 2009
- Isolation of rare circulating tumour cells in cancer patients by microchip technologyNature, 2007
- Circulating Tumor Cells at Each Follow-up Time Point during Therapy of Metastatic Breast Cancer Patients Predict Progression-Free and Overall SurvivalClinical Cancer Research, 2006